Hilltop National Bank’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.41M Sell
10,944
-252
-2% -$29.5K 0.3% 78
2026
Q1
$1.35M Buy
11,196
+796
+8% +$91.9K 0.32% 78
2025
Q4
$1.09M Sell
10,400
-215
-2% -$20.2K 0.26% 99
2025
Q3
$891K Sell
10,615
-3
-0% -$247 0.22% 107
2025
Q2
$841K Buy
+10,618
New +$844K 0.22% 107
2024
Q4
$1.98M Buy
19,934
+1,115
+6% +$115K 0.6% 44
2024
Q3
$2.14M Buy
18,819
+537
+3% +$63.8K 0.65% 38
2024
Q2
$2.26M Buy
18,282
+6,165
+51% +$794K 0.73% 31
2024
Q1
$1.6M Buy
+12,117
New +$1.49M 0.54% 45

Other funds holding MRK

Hilltop National Bank's MRK Position: Q2 2026 in Review

Hilltop National Bank reduced its Merck (MRK) stake by 2.3% in Q2 2026, selling an estimated $29.5K and leaving 10,944 shares worth $1.41M. The position accounts for 0.3% of the portfolio, ranked #78.

Hilltop National Bank first reported a position in MRK in Q1 2024 and has held it in 9 quarters since. The position peaked at $2.26M in Q2 2024. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Hilltop National Bank held 10,944 shares of Merck worth $1.41M as of Q2 2026.
  • Hilltop National Bank sold 252 Merck shares in Q2 2026, an estimated $29.5K.
  • Merck made up 0.3% of Hilltop National Bank's portfolio in Q2 2026, its #78 holding.
  • Hilltop National Bank first reported a position in Merck in Q1 2024 and has held it in 9 quarters since.
  • Hilltop National Bank's Merck position peaked at $2.26M in Q2 2024.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Hilltop National Bank's 13F filing for Q2 2026, filed 2 Jul 2026.